AzTrials
AzTrials

Mental HealthNCT03336710

Perspective on Thoughts and Feelings as a Predictor of Psychological Well-being in Daily Life, in a Community Sample

An observational study of Mental Health and Mindfulness, run by State University of New York at Buffalo at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project examines the psychological construct of decentering - a mindfulness-related construct marked by an observer perspective on one's ongoing mental processes. Specifically, this project seeks to explore the extent to which decentering modulates the relationship between people's affective states and their… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Mental Health, Mindfulness
How many people
380 participants
Where
1 siteUnited States
Study dates
6 Jul 2017to 17 Dec 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The population from which the sample will be recruited will be residents of the greater Buffalo, NY metropolitan area.

Who may be able to join

  • age 18-65, fluency in English

Who cannot join

  • current cognitive impairments (i.e., intellectual disability, dementia, current psychotic symptoms) that preclude giving informed consent and accurately answering study questions

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University at Buffalo, Department of psychology

    Buffalo, New York, 14260

Other trials in United States

About this study

Official title: Decentering in Daily Life: Underlying Mechanisms and Impact on Well-Being

This project examines the psychological construct of decentering - a mindfulness-related construct marked by an observer perspective on one's ongoing mental processes. Specifically, this project seeks to explore the extent to which decentering modulates the relationship between people's affective states and their momentary mental health and well-being, and to test the psychological processes by which decentering might exert these effects. This study includes a baseline assessment followed by a 7-day study completed from home where participants respond to brief surveys about their current experiences six times per day (i.e., an Ecological Momentary Assessment [EMA] design).

The investigators hypothesize that decentering moderates the association of extreme affect with related symptoms (i.e., elevated negative affect with depression and anxiety; elevated positive affect with mania, narcissism, and histrionic traits) and well-being, such that the association is attenuated at high levels of decentering. This will be examined using the EMA data, analyzing between-person levels (i.e., trait) as well as momentary within-person processes (i.e., concurrent and prospective states).

Read more

Further, the investigators predict that broadened attentional focus and improved self-regulation are mechanisms that contribute to the beneficial effects of decentering in daily life. This hypothesis will be examined in two ways:

  1. as individual differences, wherein greater self-regulatory abilities (e.g., higher heart rate variability) and less attentional biases towards emotional stimuli mediate the association between trait decentering and subsequent daily well-being/symptoms, and
  2. as within-person momentary levels, wherein broader attentional processes and greater self-regulation in daily life mediate the concurrent and prospective association between momentary decentering and well-being/symptoms.

Note that the study uses a multimodal assessment of each of the proposed processes. For attentional processes, a variety of parameters extracted from an emotional eye tracking paradigm will be examined. For self-regulatory abilities, assessments will include self-report, physiological (heart rate variability), and behavioral ("go / no-go" task) measures of such abilities.

Keywords
Self-control, Ecological Momentary Assessment, Attentional bias, Respiratory Sinus Arrhythmia, Affect, Emotion Regulation, Well-being, Decentering, Affective disorders
Medical subject headings
Psychological Well-Being, Self-Control, Arrhythmia, Sinus, Emotional Regulation, Mood Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03336710
Study groupRoleWhat they receive
Primary sampleCommunity sample of adults (18-65) from the greater Buffalo, NY region, oversampling people who are seeking mental health treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Momentary psychological distress

    2 items (developed new for this study) assessing the presence and impact of idiographic symptoms identified at baseline, and 4 items assessing dysphoria adapted from the Inventory of Depression and Anxiety Symptoms (IDAS)

    Measured: 6 x daily for 7 days following the baseline assessment

  2. Momentary eudaimonic well-being

    2 items assessing eudaimonic well-being adapted from Breines et al. (2008) and Lambert et al. (2013)

    Measured: 6 x daily for 7 days following the baseline assessment

  3. Momentary hedonic well-being (state positive and negative affect)

    8 items assessing hedonic well-being (positive and negative affect), taken from the Positive and Negative Affect Schedule (PANAS).

    Measured: 6 x daily for 7 days following the baseline assessment

  4. State Decentering

    4 items assessing current decentering, adapted from Fresco et al. (2007), Gillanders et al. (2014), and Shoham et al. (2017)

    Measured: 6 x daily for 7 days following the baseline assessment

  5. Trait Decentering: Experiences Questionnaire

    Experiences Questionnaire is a trait measure of decentering, which assesses the Observer Perspective aspect of decentering. From Fresco et al., (2007)

    Measured: Baseline session only

  6. Trait decentering: Valence free decentering measure

    This is an in-development measure of decentering that measures the construct of decentering without explicitly referring to negative thoughts and feelings.

    Measured: Baseline session only

  7. Trait decentering: Cognitive Fusion Questionnaire

    The Cognitive Fusion Questionnaire is a decentering measure that assesses the Reduced Struggle with Inner Experiences aspect of decentering. From Gillanders et al., (2014).

    Measured: Baseline session only

  8. Trait decentering: Toronto Mindfulness Scale-Decentering Subscale

    The Toronto Mindfulness Scale-Decentering subscale is a decentering measure that assesses the Observer Perspective aspect of decentering. From Davis, Lau, \& Cairns (2009).

    Measured: Baseline session only

Secondary outcomes (9)
  1. Self-reported momentary self-regulation

    3 questions assessing current perceived willpower \& mental exhaustion, adapted from Davisson (2013) and Milyavskaya \& Inzlicht (2017).

    Measured: 6 x daily for 7 days following the baseline assessment

  2. Self-reported momentary attentional focus

    4 attentional emotion regulation items (distraction, positive rumination, negative rumination, and reappraisal) adapted from Brans et al. (2013), Feldman et al. (2008), and Nolen-Hoeksema \& Morrow (1991)

    Measured: 6 x daily for 7 days following the baseline assessment

  3. Baseline self-regulation: Go/no-go task

    Go/no-go task asks people to respond to a large number of "go" trials (80%) and a smaller number of "no go" trials. The ability to inhibit the dominant "go" response is seen as an operative measure of self-regulatory abilities, consequently the number of "no go" signals responded to is one measure of self-regulatory abilities.

    Measured: Baseline session only

  4. Baseline self-regulation: Resting heart rate variability

    Assessed with a Polar V800 athletic watch during a 5-minute vanilla baseline and a 5-minute paced breathing task.

    Measured: Baseline session only

  5. Baseline self-regulation: Self-Control Scale (short form)

    A self-report measure of people's perceived self-control abilities and outcomes, developed by Tangney, Baumeister, \& Boone (2004).

    Measured: Baseline session only

  6. Baseline attentional breadth: Emotional eye-tracking paradigm

    Participants will view a series of emotionally expressive versus neutral faces, and the fixation time and number of fixations towards emotionally evocative (angry, sad, happy) faces will serve as indicators of attentional bias

    Measured: Baseline session only

  7. Baseline attentional breadth: Thought Control Questionnaire

    Self-report measure corresponding to various emotion regulation strategies (distraction and reappriasal)

    Measured: Baseline session only

  8. Baseline attentional breadth: Responses to Positive Affect Scale

    Self-report measure corresponding to various emotion regulation strategies (positive rumination)

    Measured: Baseline session only

  9. Baseline attentional breadth: Ruminative Responses Scale

    Self-report measure corresponding to various emotion regulation strategies (negative rumination)

    Measured: Baseline session only

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2017
  2. Study start6 Jul 2017
  3. Primary completion7 Dec 2018
  4. Study completion17 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
380 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03336710
Sponsor's protocol ID
1R21AT009470-01
Other IDs
R21AT009470
Status last verified
Jul 2019
First submitted
25 Oct 2017
Last updated
30 Jul 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IPD that underlie results in a publication will be shared.

Publications

  • Naragon-Gainey K, DeMarree KG. Structure and validity of measures of decentering and defusion. Psychol Assess. 2017 Jul;29(7):935-954. doi: 10.1037/pas0000405. Epub 2016 Oct 31.

    PubMed 27797554
  • Bernstein A, Hadash Y, Lichtash Y, Tanay G, Shepherd K, Fresco DM. Decentering and Related Constructs: A Critical Review and Metacognitive Processes Model. Perspect Psychol Sci. 2015 Sep;10(5):599-617. doi: 10.1177/1745691615594577.

    PubMed 26385999
  • Shoham A, Goldstein P, Oren R, Spivak D, Bernstein A. Decentering in the process of cultivating mindfulness: An experience-sampling study in time and context. J Consult Clin Psychol. 2017 Feb;85(2):123-134. doi: 10.1037/ccp0000154.

    PubMed 28134540
  • Naragon-Gainey K, DeMarree KG. Decentering attentuates the associations of negative affect and positive affect with psychopathology. Clinical Psychological Science. Epub 2017 Aug 11.

  • Tangney JP, Baumeister RF, Boone AL. High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers. 2004 Apr;72(2):271-324. doi: 10.1111/j.0022-3506.2004.00263.x.

    PubMed 15016066
  • Fresco DM, Moore MT, van Dulmen MH, Segal ZV, Ma SH, Teasdale JD, Williams JM. Initial psychometric properties of the experiences questionnaire: validation of a self-report measure of decentering. Behav Ther. 2007 Sep;38(3):234-46. doi: 10.1016/j.beth.2006.08.003. Epub 2007 Apr 24.

    PubMed 17697849
  • Gillanders DT, Bolderston H, Bond FW, Dempster M, Flaxman PE, Campbell L, Kerr S, Tansey L, Noel P, Ferenbach C, Masley S, Roach L, Lloyd J, May L, Clarke S, Remington B. The development and initial validation of the cognitive fusion questionnaire. Behav Ther. 2014 Jan;45(1):83-101. doi: 10.1016/j.beth.2013.09.001. Epub 2013 Sep 18.

    PubMed 24411117
  • Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.

    PubMed 3397865
  • Watson D, O'Hara MW, Simms LJ, Kotov R, Chmielewski M, McDade-Montez EA, Gamez W, Stuart S. Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS). Psychol Assess. 2007 Sep;19(3):253-68. doi: 10.1037/1040-3590.19.3.253.

    PubMed 17845118
  • Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003 Aug;85(2):348-62. doi: 10.1037/0022-3514.85.2.348.

    PubMed 12916575

Questions about this trial

What is this clinical trial studying?

An observational study of Mental Health and Mindfulness, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Momentary psychological distress (time frame: 6 x daily for 7 days following the baseline assessment). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03336710, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in